CHELMSFORD, Mass., July 23, 2013 (GLOBE NEWSWIRE) -- Brooks Automation, Inc. (Nasdaq:BRKS) announced that it signed a definitive agreement to acquire the assets and business of Matrical, Inc. for cash consideration of approximately $10 million. Matrical is a Spokane, Washington-based, privately held company established in 2001 that provides biological sample preparation, management and storage solutions to customers in Agbio, Biotech, Life Science Tools and Pharmaceutical markets. The transaction is subject to customary closing conditions and is expected to be completed within the next two weeks.
Jeffrey Farmer, Vice President & General Manager of Brooks Life Science Systems, stated, "We are enthusiastic about welcoming the founders and employees of Matrical to Brooks and foresee them making a significant contribution to the development of new solutions that further the growth of our Life Sciences business. In particular, we are excited about the product offerings and market position in Agbio that will significantly expand our penetration in this market segment."
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation, vacuum and instrumentation solutions for multiple markets including life sciences, front end semiconductor manufacturing and adjacent technology markets. Our technologies, engineering competencies and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, we have been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; we have expanded our reach to meet the needs of customers in the life sciences industry, analytical & research markets and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more information, please visit www.brooks.com.
Forward Looking Statements
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include statements regarding the expected timing of the closing of our acquisition of Matrical, Inc. and the expected growth of our life sciences business. Factors that could cause results to differ from our expectations include a possible delay in the completion of the transaction, unanticipated difficulties with integrating Matrical's business into our life sciences business and the other factors and risks that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. Brooks expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no obligation to update the information contained in this press release.